SUPERCOM LTD (SPCB)

IL0010830961 - Common Stock

8.5  -0.5 (-5.56%)

After market: 8.8 +0.3 (+3.53%)

Fundamental Rating

4

Taking everything into account, SPCB scores 4 out of 10 in our fundamental rating. SPCB was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. While SPCB seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCB has a correct valuation and a medium growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year SPCB has reported negative net income.
SPCB had negative earnings in each of the past 5 years.
In the past 5 years SPCB always reported negative operating cash flow.

1.2 Ratios

SPCB's Return On Assets of 3.09% is fine compared to the rest of the industry. SPCB outperforms 62.81% of its industry peers.
SPCB has a Return On Equity of 11.09%. This is in the better half of the industry: SPCB outperforms 76.03% of its industry peers.
Industry RankSector Rank
ROA 3.09%
ROE 11.09%
ROIC N/A
ROA(3y)-16.94%
ROA(5y)-19.82%
ROE(3y)-184.28%
ROE(5y)-170.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SPCB's Profit Margin of 5.70% is fine compared to the rest of the industry. SPCB outperforms 71.90% of its industry peers.
SPCB has a better Gross Margin (51.80%) than 89.26% of its industry peers.
SPCB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.7%
GM 51.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y0.68%

5

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SPCB has less shares outstanding
SPCB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPCB has an improved debt to assets ratio.

2.2 Solvency

SPCB has an Altman-Z score of -1.54. This is a bad value and indicates that SPCB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.54, SPCB is not doing good in the industry: 85.12% of the companies in the same industry are doing better.
SPCB has a Debt/Equity ratio of 2.17. This is a high value indicating a heavy dependency on external financing.
SPCB has a worse Debt to Equity ratio (2.17) than 95.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z -1.54
ROIC/WACCN/A
WACC5.74%

2.3 Liquidity

A Current Ratio of 5.10 indicates that SPCB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.10, SPCB belongs to the top of the industry, outperforming 82.64% of the companies in the same industry.
A Quick Ratio of 4.66 indicates that SPCB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.66, SPCB belongs to the best of the industry, outperforming 85.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 4.66

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.38% over the past year.
Looking at the last year, SPCB shows a small growth in Revenue. The Revenue has grown by 4.25% in the last year.
Measured over the past years, SPCB shows a decrease in Revenue. The Revenue has been decreasing by -9.34% on average per year.
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)4.25%
Revenue growth 3Y-17.54%
Revenue growth 5Y-9.34%
Sales Q2Q%1.95%

3.2 Future

Based on estimates for the next years, SPCB will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.90% on average per year.
SPCB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.94% yearly.
EPS Next Y77.78%
EPS Next 2Y42.83%
EPS Next 3Y27.1%
EPS Next 5Y18.9%
Revenue Next Year37.9%
Revenue Next 2Y45.91%
Revenue Next 3Y30.88%
Revenue Next 5Y26.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SPCB. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 3.79, the valuation of SPCB can be described as very cheap.
SPCB's Price/Forward Earnings ratio is rather cheap when compared to the industry. SPCB is cheaper than 99.17% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.73. SPCB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 3.79

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPCB is valued a bit cheaper than the industry average as 67.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.93

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SPCB's earnings are expected to grow with 27.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3Y27.1%

0

5. Dividend

5.1 Amount

SPCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUPERCOM LTD

NASDAQ:SPCB (1/6/2025, 5:20:02 PM)

After market: 8.8 +0.3 (+3.53%)

8.5

-0.5 (-5.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners1.17%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.62M
Analysts82.86
Price Target12.24 (44%)
Short Float %1.65%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)226.05%
Min EPS beat(2)156.02%
Max EPS beat(2)296.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.57%
Min Revenue beat(2)17.85%
Max Revenue beat(2)23.28%
Revenue beat(4)4
Avg Revenue beat(4)21.66%
Min Revenue beat(4)1.03%
Max Revenue beat(4)44.46%
Revenue beat(8)8
Avg Revenue beat(8)38.35%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)263.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.79
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 29.01
EV/EBITDA 15.93
EPS(TTM)-2.43
EYN/A
EPS(NY)2.24
Fwd EY26.4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS15.61
BVpS8.03
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.09%
ROE 11.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.7%
GM 51.8%
FCFM N/A
ROA(3y)-16.94%
ROA(5y)-19.82%
ROE(3y)-184.28%
ROE(5y)-170.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.72%
GM growth 5Y0.68%
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA 12.23
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.1
Quick Ratio 4.66
Altman-Z -1.54
F-ScoreN/A
WACC5.74%
ROIC/WACCN/A
Cap/Depr(3y)89.28%
Cap/Depr(5y)71.34%
Cap/Sales(3y)12.83%
Cap/Sales(5y)11.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y77.78%
EPS Next 2Y42.83%
EPS Next 3Y27.1%
EPS Next 5Y18.9%
Revenue 1Y (TTM)4.25%
Revenue growth 3Y-17.54%
Revenue growth 5Y-9.34%
Sales Q2Q%1.95%
Revenue Next Year37.9%
Revenue Next 2Y45.91%
Revenue Next 3Y30.88%
Revenue Next 5Y26.94%
EBIT growth 1Y44.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.1%
OCF growth 3YN/A
OCF growth 5YN/A